Product Details for: Lymphir

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
For Injection
Intravenous
300MCG
Single-Dose Vial
351(a)
Lymphir
Rx
Proper Name
denileukin diftitox-cxdl
BLA Number
761312
Applicant
Citius Oncology, Inc.
Original Approval Date
August 7, 2024
Date of First Licensure